"Raw data showed results were inconclusive in respect of the proposed 3 biomarker ColoSTAT™ panel, as a result of the aberrant measured performance of one of the lead biomarkers. This result may be related to the stability or performance properties of the specific batch of commercially sourced assay kit, further research and development work is required..."
Do you understand the risk associated with this stock? Forget about the comparisons with the FIT and a colonoscopy. RHY's blood test doesn't even work yet...
IPO - Rhythm Biosciences Limited, page-142
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5969 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 5500 | 1 |
View Market Depth
| Last trade - 16.16pm 18/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable
